Skip to content

California · Nonprofit

Lazarex Cancer Foundation

Lazarex Cancer Foundation (California) receives grants from 40 organizations whose IRS filings report $4,997,635 to it, the largest being EAST BAY COMMUNITY FOUNDATION ($1,975,367). 17 of them have funded it in more than one year, and 93% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$865k
Funders on record
40
Grants received
$5.0M
Net assets
$609k
17/40 repeat funderspeak grant-dependency 42%
01What it does

What Lazarex Cancer Foundation does

Mission

We strive to improve cancer health outcomes, FDA cancer clinical trial diversity and enrollment, and patient access to care by providing assistance with clinical trial navigation, reimbursing trial related travel costs, and partnering with at-risk communities to mobilize resources.

As stated on its FY2025 Form 990.

Programs

On its FY2025 return the organization reported a significant change in how it conducts a program.

Board of Directors approved a plan to dissolve the Organization on June 26, 2025. Management expects the dissolution and liquidation process to be substantially completed by March 31, 2026.

Its own explanation, from Schedule O of that return (Part III, line 3).

  1. Lazarex Cancer Wellness Hub Program: Lazarex Cancer Wellness Hubs operated in Philadelphia through Drexel University and Penn Abramson, in Los Angeles through USC Norris, and in the San Francisco East Bay area in collaboration with Monument Crisis Center. The goal of the Lazarex Cancer Wellness Hub Program is to generate a replicable program that is place based, culturally appropriate, and community driven, that operates in at-risk communities of color across the continuum of cancer care to improve cancer health disparities and improve cancer health outcomes.

    $1,391,547 spentof which $506,016 as grants
    96% of program spending
  2. Lazarex CARE Program: This program focuses on improving the outcome of cancer care for advanced stage cancer patients and the medically underserved by identifying FDA clinical trial options, providing assistance with out-of-pocked travel expenses for clinical trial participation and a travel companion if needed, and by facilitating community outreach and engagement.

    $62,841 spentof which $62,841 as grants
    4% of program spending

The 2 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $1,454,388.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($5.4M) Expenses 100 ($3.3M) Net assets 100 ($2.4M)2018 Revenue 56 ($3.0M) Expenses 67 ($2.2M) Net assets 132 ($3.2M)2019 Revenue 138 ($7.4M) Expenses 82 ($2.7M) Net assets 327 ($7.9M)2020 Revenue 44 ($2.4M) Expenses 86 ($2.9M) Net assets 307 ($7.4M)2021 Revenue 48 ($2.6M) Expenses 99 ($3.3M) Net assets 279 ($6.7M)2022 Revenue 61 ($3.3M) Expenses 150 ($5.0M) Net assets 209 ($5.1M)2023 Revenue 70 ($3.7M) Expenses 187 ($6.2M) Net assets 106 ($2.6M)2024 Revenue 48 ($2.6M) Expenses 100 ($3.3M) Net assets 74 ($1.8M)2025 Revenue 16 ($865k) Expenses 62 ($2.0M) Net assets 25 ($609k)
'17'18'19'20'21'22'23'24'25
Revenue (16)Expenses (62)Net assets (25)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $3.3M to $8.2M (+146%).

$2.6M
$3.3M
$8.2M
$8.0M
$7.7M
$6.9M
$4.1M
$2.2M
$690k
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2021 9% · 2025 6%. Grants only. Government contracts and fees sit inside program revenue.

94% of Lazarex Cancer Foundation’s revenue is contributions — more donation-reliant than the typical peer (57% for the typical peer).

This organization
Typical peer · 24,946 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 6 of the last 9 reported years ran a deficit.

$2.0M
’17
$783k
’18
$4.7M
’19
−$513k
’20
−$683k
’21
−$1.7M
’22
−$2.5M
’23
−$766k
’24
−$1.2M
’25
4.0
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Clay Jackson

Chairman

As listed on its FY2025 Form 990.

The chief executive listed changed between the FY2019 and FY2020, and between the FY2021 and FY2022 filings.

'17'18'19'20'21'22'23'24'25
Listed131314131111131313
Joined·+0+2+1+2+3+4+1+2
No longer listed·01243212
03Who funds it

Who funds it, year by year

2017 → 2023: the base narrowed from 12 funders to 10 funders, grant income fell $1.8M → $132k.

16 of 40 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 93% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of Lazarex Cancer Foundation’s funders (the co-funder graph). Top 30 of 40 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

Lazarex Cancer Foundation leans on a few funders — its largest provides 40% of grant income and the top three 72%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

96% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Lazarex Cancer Foundation.

40%
largest funder
72%
top three
~5
effective funders

Largest funder’s share by year: 2017 67% · 2018 58% · 2019 52% · 2020 26% · 2021 43% · 2022 40% · 2023 26% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

27% of Lazarex Cancer Foundation's funders are still giving 3 years after their first grant; 43% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

93% of Lazarex Cancer Foundation's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $369k that is directly attributable, 53% of it comes from California funders.

IL
NY
PA
CA
DE
NC
TX
FL

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
California out of state home

Funder states come from each funder’s own filing. $4.6M arriving through sponsors registered in 9 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

Lazarex Cancer Foundation's revenue fell 84% between 2017 and 2025.

Operating margin−137% · bottom quartile
Months of reserve4.0mo · below the median
Revenue growth (annualized)−20% · bottom quartile

this organization peer median middle 50% of peers· 16,849 education nonprofits $100k–$1M, FY2025

Organizations like Lazarex Cancer Foundation

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

71% of spending goes to programs.

Program 71%Management 15%Fundraising 14%

Governance

11
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990–Audited financials

Public support

46%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 20 states

NH
IL
NY
MA
OR
OH
NJ
CA
KY
VA
MD
NM
KS
AR
TN
NC
HI
MS
AL
FL

Screen this organization

A dated, signed PDF of the compliance screen for Lazarex Cancer Foundation: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds Lazarex Cancer Foundation?
Lazarex Cancer Foundation (California) receives grants from 40 organizations whose IRS filings report $4,997,635 to it, the largest being EAST BAY COMMUNITY FOUNDATION ($1,975,367). 17 of them have funded it in more than one year, and 93% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does Lazarex Cancer Foundation have?
IRS filings report 40 organizations giving $4,997,635 in grants to Lazarex Cancer Foundation, 17 of which have funded it in more than one year.
Who is the largest funder of Lazarex Cancer Foundation?
EAST BAY COMMUNITY FOUNDATION is the largest funder on record, with $1,975,367 in grants. The full list of funders is on this page.
How can an organization like Lazarex Cancer Foundation find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 40 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing